3,4-dihydroxyphenylacetaldehyde and Neurodegenerative Diseases

3,4-dihydroxyphenylacetaldehyde has been researched along with Neurodegenerative Diseases in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Goldstein, DS	1
Goldstein, DS; Kopin, IJ; Sharabi, Y	1
Bubacco, L; Plotegher, N	1
Fernandez, E; Goldstein, DS; Martinez, PA; Strong, R; Sullivan, P; Wey, MC	1
Burke, WJ; Chung, HD; Franko, M; Johnson, EM; Kristal, BS; Kumar, VB; Lampe, P; Li, SW; Ruggiero, DA; Williams, EA; Zahm, DS	1

Reviews

4 review(s) available for 3,4-dihydroxyphenylacetaldehyde and Neurodegenerative Diseases

Article	Year
The catecholaldehyde hypothesis: where MAO fits in. Journal of neural transmission (Vienna, Austria : 1996), 2020, Volume: 127, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Dopamine; Humans; Monoamine Oxidase; Neurodegenerative Diseases; Neurons	2020
Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders. Pharmacology & therapeutics, 2014, Volume: 144, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Animals; Apoptosis; Catecholamines; Humans; Lipid Peroxidation; Neurodegenerative Diseases; Neurons; Oxidation-Reduction; Parkinson Disease	2014
Lysines, Achilles' heel in alpha-synuclein conversion to a deadly neuronal endotoxin. Ageing research reviews, 2016, Volume: 26 Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehydes; alpha-Synuclein; Brain; Dopamine; Humans; Lysine; Metabolism; Neurodegenerative Diseases; Neurons	2016
Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases. Neurotoxicology, 2004, Volume: 25, Issue:1-2 Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehydes; Animals; Apoptosis; Catecholamines; Catechols; Humans; Neurodegenerative Diseases	2004

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and Neurodegenerative Diseases

Article	Year
Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease. PloS one, 2012, Volume: 7, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Body Weight; Cognition Disorders; Cytosol; Disease Models, Animal; Dopamine; Female; Genotype; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Neurons; Parkinson Disease; Time Factors; Tyrosine 3-Monooxygenase	2012

Article

Year

Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.

PloS one, 2012, Volume: 7, Issue:2

Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Body Weight; Cognition Disorders; Cytosol; Disease Models, Animal; Dopamine; Female; Genotype; Male; Mice; Mice, Transgenic; Mitochondria; NAD; Neurodegenerative Diseases; Neurons; Parkinson Disease; Time Factors; Tyrosine 3-Monooxygenase

2012